Health

Bharat Biotech Unveils 'Hillchol': A New Breakthrough Cholera Vaccine | Health Live

Hyderabad-based Bharat Biotech, renowned for its COVID-19 vaccines, has introduced a new oral vaccine named 'Hillchol' to combat cholera. This vaccine requires two doses, with the second dose administered 14 days after the first. It is approved for children over the age of one. Bharat Biotech reports that Hillchol (BBV131) has been developed under a licensing agreement with Heliman Laboratories in the USA. The company asserts that the vaccine has demonstrated proven safety, immunogenicity, and efficacy. The launch of Hillchol marks a significant advancement in cholera prevention, aiming to enhance public health efforts against this potentially deadly disease. Watch till the end to know full details.

Hyderabad-based Bharat Biotech, renowned for its COVID-19 vaccines, has introduced a new oral vaccine named 'Hillchol' to combat cholera. This vaccine requires two doses, with the second dose administered 14 days after the first. It is approved for children over the age of one.

Bharat Biotech reports that Hillchol (BBV131) has been developed under a licensing agreement with Heliman Laboratories in the USA. The company asserts that the vaccine has demonstrated proven safety, immunogenicity, and efficacy. The launch of Hillchol marks a significant advancement in cholera prevention, aiming to enhance public health efforts against this potentially deadly disease.

Watch till the end to know full details..